- Home
- CNTB vs NAUT Comparison
CNTB vs NAUT Comparison
Compare CNTB & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- NAUT
- Stock Information
- Founded
- CNTB 2012
- NAUT 2016
- Country
- CNTB United States
- NAUT United States
- Employees
- CNTB N/A
- NAUT N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- NAUT Biotechnology: Laboratory Analytical Instruments
- Sector
- CNTB Health Care
- NAUT Industrials
- Exchange
- CNTB Nasdaq
- NAUT Nasdaq
- Market Cap
- CNTB 90.3M
- NAUT 104.7M
- IPO Year
- CNTB 2021
- NAUT N/A
- Fundamental
- Price
- CNTB N/A
- NAUT $0.90
- Analyst Decision
- CNTB Strong Buy
- NAUT Strong Sell
- Analyst Count
- CNTB 2
- NAUT 1
- Target Price
- CNTB $7.50
- NAUT $1.75
- AVG Volume (30 Days)
- CNTB 88.0K
- NAUT 372.5K
- Earning Date
- CNTB 11-13-2025
- NAUT 10-28-2025
- Dividend Yield
- CNTB N/A
- NAUT N/A
- EPS Growth
- CNTB N/A
- NAUT N/A
- EPS
- CNTB N/A
- NAUT N/A
- Revenue
- CNTB $1,965,000.00
- NAUT N/A
- Revenue This Year
- CNTB N/A
- NAUT N/A
- Revenue Next Year
- CNTB $453,067.90
- NAUT N/A
- P/E Ratio
- CNTB N/A
- NAUT N/A
- Revenue Growth
- CNTB N/A
- NAUT N/A
- 52 Week Low
- CNTB $1.23
- NAUT $0.62
- 52 Week High
- CNTB $2.20
- NAUT $3.03
- Technical
- Relative Strength Index (RSI)
- CNTB 58.99
- NAUT 65.71
- Support Level
- CNTB $1.36
- NAUT $0.84
- Resistance Level
- CNTB $1.88
- NAUT $0.92
- Average True Range (ATR)
- CNTB 0.15
- NAUT 0.06
- MACD
- CNTB 0.04
- NAUT 0.01
- Stochastic Oscillator
- CNTB 99.48
- NAUT 90.92
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.